Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cortexyme, Inc. - Common Stock (NQ:CRTX)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 29, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cortexyme, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
CORTEXYME ALERT: Bragar Eagel & Squire, P.C. is Investigating Cortexyme, Inc. on Behalf of Cortexyme Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
NASDAQ:CRTX Shareholder Notice: Investigation over Potential Securities Laws Violations by Cortexyme, Inc.
San Diego, CA -- (SBWIRE) -- 02/24/2022 -- Cortexyme, Inc. is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
CORTEXYME ALERT: Bragar Eagel & Squire, P.C. Is Investigating Cortexyme, Inc. on Behalf of Cortexyme Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via Business Wire
Investigation Notice: The Schall Law Firm Encourages Investors in Cortexyme, Inc. with Losses of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Why Cortexyme Shares Are Falling
Cortexyme Inc (NASDAQ:CRTX) shares are trading lower by 29... 
Via Benzinga
Cortexyme Stock Plunges On FDA Hold On Atuzaginstat's IND
The  
Via Benzinga
Investigation Alert: The Schall Law Firm Encourages Investors in Cortexyme, Inc. with Losses of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Ongoing Investigation Reminder: The Schall Law Firm Encourages Investors in Cortexyme, Inc. with Losses of $100,000 to Contact the Firm
Los Angeles - (NewMediaWire) - February 16, 2022 - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cortexyme,... 
Via NewMediaWire
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Cortexyme, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Cortexyme, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 147 companies achieved new lows for the year. Significant Points From Today's 52-Week Lows: PayPal Holdings (NASDAQ:PYPL) was the biggest company... 
Via Benzinga
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Cortexyme, Inc. Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation – CRTX
From Rosen Law Firm
Via Business Wire
52 Biggest Movers From Yesterday
Gainers ION Geophysical Corporation (NYSE: IO) shares surged 29.8% to settle at $0.5969. Synaptogenix, Inc. (NASDAQ: SNPX) climbed 29.4% to close at $10.09. Synaptogenix... 
Via Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
Gainers Biofrontera Inc. (NASDAQ: BFRI) shares climbed 30.7% to $4.4095 after the company provided an update on patient recruitment for the Phase III study for the treatment of... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Windtree Therapeutics (NASDAQ:WINT) stock rose 25.6% to $1.42 during Tuesday's regular session. Trading volume for Windtree Therapeutics's stock is 652.4K... 
Via Benzinga
5 Short-Squeeze Candidates to Watch Today: IMMX, ALTM, GLTB, CRTX and TSRI
Short-squeeze stocks continue to be hot with traders and we're going over five candidates that investors will want to watch today. 
Via InvestorPlace
Cortexyme Announces Pipeline Update and Anticipated 2022 Milestones
From Cortexyme, Inc.
Via Business Wire
Cortexyme Announces Change in Executive Leadership Team
From Cortexyme, Inc.
Via Business Wire
41 Biggest Movers From Yesterday
Gainers Ebang International Holdings Inc. (NASDAQ: EBON) shares gained 35.4% to settle at $1.09 on Wednesday as investors weighed the Federal Reserve Reserve decision to leave... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2022
Upgrades 
Via Benzinga
Mid-Afternoon Market Update: Nasdaq Surges Over 300 Points; Fed Leaves Rates Unchanged
Toward the end of trading Wednesday, the Dow traded up 0.82% to 34,578.14 while the NASDAQ rose 2.33% to 13,855.27. The S&P also rose, gaining, 1.52% to 4,422.86. The U.S. has... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Rani Therapeutics Hldgs (NASDAQ:RANI 
Via Benzinga
Mid-Day Market Update: Gold Down 1%; Corning Shares Gain On Upbeat Earnings
Midway through trading Wednesday, the Dow traded up 0.60% to 34,502.46 while the NASDAQ rose 1.74% to 13,775.38. The S&P also rose, gaining, 1.09% to 4,403.86. The U.S. has... 
Via Benzinga
32 Stocks Moving In Wednesday's Mid-Day Session
Gainers Exela Technologies, Inc. (NASDAQ: XELA) rose 32% to $0.7262 after the company announced a share buyback of up to 100 million shares of common stock at $1 per share... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's morning session, 34 stocks hit new 52-week lows. Things to Consider About Today's 52-Week Lows: Illumina (NASDAQ:ILMN) was the biggest company... 
Via Benzinga
Mid-Morning Market Update: Markets Open Higher; AT&T Earnings Top Expectations
Following the market opening Wednesday, the Dow traded up 1.14% to 34,689.16 while the NASDAQ rose 2.15% to 13,830.02. The S&P also rose, gaining, 1.61% to 4,426.80. The U.S.... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Vaccinex (NASDAQ:VCNX) shares moved upwards by 30.4% to $1.33 during Wednesday's pre-market session. The market value of their outstanding shares is at $40.9... 
Via Benzinga
Cortexyme Announces Clinical Hold on Atuzaginstat’s Investigational New Drug Application
From Cortexyme, Inc.
Via Business Wire
3 Most-Shorted Stocks at 52-Week Lows to Buy
In a market made up of stocks, these three most-shorted stocks look poised to deliver a much happier 2022 to bullish investors. 
Via InvestorPlace
Top Short Squeeze Plays
Since the market has dropped so much, now might be the time to look for short squeeze opportunities. 
Via Talk Markets
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.